Literature DB >> 16557622

Inhibition of early and late phase allergic reactions by Euphorbia hirta L.

G D Singh1, P Kaiser, M S Youssouf, S Singh, A Khajuria, A Koul, S Bani, B K Kapahi, N K Satti, K A Suri, R K Johri.   

Abstract

A 95% ethanol extract from whole aerial parts of Euphorbia hirta (EH A001) showed antihistaminic, antiinflammatory and immunosuppressive properties in various animal models. EH A001 inhibited rat peritoneal mast cell degranulation triggered by compound 48/80. It significantly inhibited dextran-induced rat paw edema. EH A001 prevented eosinophil accumulation and eosinophil peroxidase activity and reduced the protein content in bronchoalveolar lavage fluid (BALF) in a 'mild' model of asthma. Moreover, the CD4/CD8 ratio in peripheral blood was suppressed. EH A001 attenuated the release of interleukin-4 (IL-4) and augmented interferon-gamma (IFN-gamma) in ovalbumin-sensitized mouse splenocytes. The results were compared with the effects of known compounds, ketotifen, cetirizine and cyclophosphamide. These findings demonstrated that Euphorbia hirta possessed significant activity to prevent early and late phase allergic reactions. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557622     DOI: 10.1002/ptr.1844

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

1.  A molecular pharmacology study into the anti-inflammatory actions of Euphorbia hirta L. on the LPS-induced RAW 264.7 cells through selective iNOS protein inhibition.

Authors:  Mei-Fen Shih; Yih-Dih Cheng; Chia-Rui Shen; Jong-Yuh Cherng
Journal:  J Nat Med       Date:  2010-07       Impact factor: 2.343

2.  Immunosuppressive effects of Euphorbia hirta in experimental animals.

Authors:  Sheikh Fayaz Ahmad; Beenish Khan; Sarang Bani; Anpurna Kaul; Phalisteen Sultan; Sheikh Abid Ali; N K Satti; Saleh A Bakheet; Sabry M Attia; Khairy M A Zoheir; Adel R A Abd-Allah
Journal:  Inflammopharmacology       Date:  2012-06-19       Impact factor: 4.473

3.  Modulation of Th1 cytokines and inflammatory mediators by Euphorbia hirta in animal model of adjuvant-induced arthritis.

Authors:  Sheikh Fayaz Ahmad; Phalisteen Sultan; Abdelkader E Ashour; Tajdar Husain Khan; Sabry M Attia; Saleh A Bakheet; Adel R A Abd-Allah
Journal:  Inflammopharmacology       Date:  2012-12-11       Impact factor: 4.473

Review 4.  A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.

Authors:  Rambod Abiri; Hazandy Abdul-Hamid; Oksana Sytar; Ramin Abiri; Eduardo Bezerra de Almeida; Surender K Sharma; Victor P Bulgakov; Randolph R J Arroo; Sonia Malik
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

5.  Chemical analysis, inhibition of biofilm formation and biofilm eradication potential of Euphorbia hirta L. against clinical isolates and standard strains.

Authors:  Shanmugapriya Perumal; Roziahanim Mahmud
Journal:  BMC Complement Altern Med       Date:  2013-12-09       Impact factor: 3.659

6.  Optimization of Extraction Conditions of Phytochemical Compounds and Anti-Gout Activity of Euphorbia hirta L. (Ara Tanah) Using Response Surface Methodology and Liquid Chromatography-Mass Spectrometry (LC-MS) Analysis.

Authors:  Fazleen Izzany Abu Bakar; Mohd Fadzelly Abu Bakar; Norazlin Abdullah; Susi Endrini; Sri Fatmawati
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-27       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.